Literature DB >> 24860097

Synthesis of high titer infectious prions with cofactor molecules.

Surachai Supattapone1.   

Abstract

Recently, synthetic prions with a high level of specific infectivity have been produced from chemically defined components in vitro. A major insight arising from these studies is that various classes of host-encoded cofactor molecules such as phosphatidylethanolamine and RNA molecules are required to form and maintain the specific conformation of infectious prions. Synthetic mouse prions formed with phosphatidylethanolamine exhibit levels of specific infectivity ∼1 million-fold greater than "protein-only" prions (Deleault, N. R., Walsh, D. J., Piro, J. R., Wang, F., Wang, X., Ma, J., Rees, J. R., and Supattapone, S. (2012) Proc. Natl. Acad. Sci. U.S.A. 109, E1938-E1946). Moreover, cofactor molecules also appear to regulate prion strain properties by limiting the potential conformations of the prion protein (see Deleault et al. above). The production of fully infectious synthetic prions provides new opportunities to study the mechanism of prion infectivity directly by structural and biochemical methods.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cofactor; Infectivity; Phosphatidylethanolamine; Phospholipid; Prion; Protein Misfolding; RNA; Synthetic

Mesh:

Substances:

Year:  2014        PMID: 24860097      PMCID: PMC4106305          DOI: 10.1074/jbc.R113.511329

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Authors:  C Wong; L W Xiong; M Horiuchi; L Raymond; K Wehrly; B Chesebro; B Caughey
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions.

Authors:  Nathan R Deleault; Daniel J Walsh; Justin R Piro; Fei Wang; Xinhe Wang; Jiyan Ma; Judy R Rees; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

3.  Changes in prion replication environment cause prion strain mutation.

Authors:  Nuria Gonzalez-Montalban; Young Jin Lee; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  FASEB J       Date:  2013-05-31       Impact factor: 5.191

4.  Stabilization of a prion strain of synthetic origin requires multiple serial passages.

Authors:  Natallia Makarava; Gabor G Kovacs; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

5.  Strain-specific role of RNAs in prion replication.

Authors:  Paula Saá; Gian Franco Sferrazza; Gregory Ottenberg; Anja M Oelschlegel; Kerri Dorsey; Corinne I Lasmézas
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

6.  Post-translational changes to PrP alter transmissible spongiform encephalopathy strain properties.

Authors:  Enrico Cancellotti; Sukhvir P Mahal; Robert Somerville; Abigail Diack; Deborah Brown; Pedro Piccardo; Charles Weissmann; Jean C Manson
Journal:  EMBO J       Date:  2013-02-08       Impact factor: 11.598

7.  Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids.

Authors:  Nathan R Deleault; Justin R Piro; Daniel J Walsh; Fei Wang; Jiyan Ma; James C Geoghegan; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

8.  Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.

Authors:  Natallia Makarava; Gabor G Kovacs; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

9.  Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology.

Authors:  Gian Mario Cosseddu; Romolo Nonno; Gabriele Vaccari; Cecilia Bucalossi; Natalia Fernandez-Borges; Michele Angelo Di Bari; Joaquin Castilla; Umberto Agrimi
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

10.  Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.

Authors:  Andrew G Timmes; Roger A Moore; Elizabeth R Fischer; Suzette A Priola
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

View more
  26 in total

1.  Incongruity between Prion Conversion and Incubation Period following Coinfection.

Authors:  Katie A Langenfeld; Ronald A Shikiya; Anthony E Kincaid; Jason C Bartz
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

Review 2.  Prions and prion-like proteins.

Authors:  Paul E Fraser
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

Review 3.  Prion Strain Diversity.

Authors:  Jason C Bartz
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

4.  Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases.

Authors:  Giuseppe Legname; Tommaso Virgilio; Edoardo Bistaffa; Chiara Maria Giulia De Luca; Marcella Catania; Paola Zago; Elisa Isopi; Ilaria Campagnani; Fabrizio Tagliavini; Giorgio Giaccone; Fabio Moda
Journal:  Prion       Date:  2018-05-18       Impact factor: 3.931

Review 5.  Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.

Authors:  Arun Khadka; Jereme G Spiers; Lesley Cheng; Andrew F Hill
Journal:  Cell Tissue Res       Date:  2022-04-08       Impact factor: 5.249

Review 6.  Cofactor molecules: Essential partners for infectious prions.

Authors:  Surachai Supattapone
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-24       Impact factor: 3.622

7.  Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity.

Authors:  Kelvin C Luk; Dustin J Covell; Victoria M Kehm; Bin Zhang; Insung Y Song; Matthew D Byrne; Rose M Pitkin; Samantha C Decker; John Q Trojanowski; Virginia M-Y Lee
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

8.  Dissociation of recombinant prion autocatalysis from infectivity.

Authors:  Geoffrey P Noble; Surachai Supattapone
Journal:  Prion       Date:  2015       Impact factor: 3.931

Review 9.  Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nat Neurosci       Date:  2018-09-26       Impact factor: 24.884

10.  Pre-amyloid oligomers of the proteotoxic RepA-WH1 prionoid assemble at the bacterial nucleoid.

Authors:  María Moreno-Del Álamo; Susana Moreno-Díaz de la Espina; M Elena Fernández-Tresguerres; Rafael Giraldo
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.